Prexa Pharmaceuticals prexainc.com


Public lists: Pharma Startups (4732)

Prexa Pharmaceuticals develops product candidates designed to enhance the action of the neurotransmitter dopamine, potentially providing new alternatives to treating CNS diseases and disorders such as ADHD, depression, and Parkinson's disease.

Prexa Pharmaceuticals develops product candidates designed to enhance the action of the neurotransmitter dopamine, potentially providing new alternatives to treating CNS diseases and disorders such as ADHD, depression, and Parkinson's disease.

Company (Alive / Active)

Phone:

Fax:

184 High Street
4th Floor
Boston, 02110
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Prexa Pharmaceuticals $8.5M May 11, 2011

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Prexa Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Dopamine transporter inhibitors for use in treatment of movement disorders and other cns indications Feb 21, 2006 Sep 04, 2012 Patent